Penn Medicine’s ODC collaborates with FAST to develop gene therapy for Angelman syndrome – News-Medical.net
News-Medical.net |
Penn Medicine's ODC collaborates with FAST to develop gene therapy for Angelman syndrome
News-Medical.net Penn Medicine's Orphan Disease Center (ODC) announces a new partnership with FAST (Foundation for Angelman Syndrome Therapeutics) to study gene therapy approaches to treat Angelman syndrome (AS). FAST will provide funding to establish a gene … Penn Gene Therapy Pioneer Teams Up with FAST in Race to Cure Angelman Syndrome |
